Horizon Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Buy
30,717
+8,774
+40% +$723K 0.03% 430
2025
Q4
$1.87M Sell
21,943
-2,877
-12% -$236K 0.02% 483
2025
Q3
$1.93M Buy
24,820
+8,622
+53% +$674K 0.03% 474
2025
Q2
$1.27M Buy
16,198
+7,682
+90% +$573K 0.02% 508
2025
Q1
$617K Buy
8,516
+269
+3% +$19.3K 0.02% 346
2024
Q4
$611K Buy
8,247
+71
+0.9% +$4.97K 0.02% 332
2024
Q3
$540K Sell
8,176
-106
-1% -$7.7K 0.01% 353
2024
Q2
$765K Buy
8,282
+36
+0.4% +$3.19K 0.02% 295
2024
Q1
$788K Sell
8,246
-18
-0.2% -$1.51K 0.02% 281
2023
Q4
$630K Buy
8,264
+4,095
+98% +$285K 0.02% 300
2023
Q3
$289K Sell
4,169
-24
-0.6% -$1.93K 0.01% 417
2023
Q2
$396K Buy
4,193
+686
+20% +$59.6K 0.01% 359
2023
Q1
$290K Sell
3,507
-2,736
-44% -$215K 0.01% 410
2022
Q4
$466K Buy
+6,243
New +$481K 0.01% 382
2022
Q3
Sell
-5,050
Closed -$480K 494
2022
Q2
$480K Sell
5,050
-1,381
-21% -$143K 0.02% 290
2022
Q1
$757K Buy
+6,431
New +$721K 0.02% 267
2021
Q4
Sell
-6,473
Closed -$733K 493
2021
Q3
$733K Buy
+6,473
New +$739K 0.02% 253
2019
Q2
Sell
-3,408
Closed -$217K 558
2019
Q1
$217K Buy
+3,408
New +$194K 0.01% 368

Other funds holding EW

Horizon Investments's EW Position: Q1 2026 in Review

Horizon Investments increased its Edwards Lifesciences (EW) stake by 40% in Q1 2026, buying an estimated $723K and bringing the position to 30,717 shares worth $2.46M. The position accounts for 0.03% of the portfolio, ranked #430.

Horizon Investments first reported a position in EW in Q1 2019 and has held it in 18 quarters since. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Horizon Investments held 30,717 shares of Edwards Lifesciences worth $2.46M as of Q1 2026.
  • Horizon Investments bought 8,774 Edwards Lifesciences shares in Q1 2026, an estimated $723K.
  • Edwards Lifesciences made up 0.03% of Horizon Investments's portfolio in Q1 2026, its #430 holding.
  • Horizon Investments first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 18 quarters since.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.